Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippon Gohsei, formally known as The Nippon Synthetic Chemical Industry Co., Ltd., was a leading Japanese chemical manufacturer specializing in functional polymers and specialty chemicals. The company was widely recognized for its high-performance products such as Soarnol (EVOH) and Gohsenol (PVOH), which are utilized across the pharmaceutical and healthcare industries for drug delivery systems, medical packaging, and as excipients. In 2019, Nippon Gohsei was formally merged into Mitsubishi Chemical Corporation to consolidate the group's specialty chemical operations. Its expertise in polymer chemistry continues to support the development of advanced medical devices and controlled-release pharmaceutical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nippon Gohsei.